Traws Pharma (TRAW) Return on Sales (2016 - 2025)
Historic Return on Sales for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to 5.55%.
- Traws Pharma's Return on Sales rose 1442100.0% to 5.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.55%, marking a year-over-year increase of 6208200.0%. This contributed to the annual value of 629.97% for FY2024, which is 5401600.0% down from last year.
- Latest data reveals that Traws Pharma reported Return on Sales of 5.55% as of Q3 2025, which was up 1442100.0% from 0.46% recorded in Q2 2025.
- Traws Pharma's 5-year Return on Sales high stood at 0.46% for Q2 2025, and its period low was 2164.0% during Q2 2024.
- For the 5-year period, Traws Pharma's Return on Sales averaged around 189.32%, with its median value being 81.49% (2021).
- In the last 5 years, Traws Pharma's Return on Sales crashed by -20831200bps in 2024 and then soared by 21635400bps in 2025.
- Traws Pharma's Return on Sales (Quarter) stood at 67.2% in 2021, then plummeted by -52bps to 102.39% in 2022, then rose by 22bps to 79.68% in 2023, then decreased by -18bps to 94.25% in 2024, then skyrocketed by 94bps to 5.55% in 2025.
- Its last three reported values are 5.55% in Q3 2025, 0.46% for Q2 2025, and 91.28% during Q1 2025.